The deaf and the dumb: the biology of ErbB-2 and ErbB-3 - PubMed (original) (raw)
Review
The deaf and the dumb: the biology of ErbB-2 and ErbB-3
Ami Citri et al. Exp Cell Res. 2003.
Abstract
ErbB-2 (also called HER2/neu) and ErbB-3 are closely related to the epidermal growth factor receptor (EGFR/ErbB-1), but unlike EGFR, ErbB-2 is a ligandless receptor, whereas ErbB-3 lacks tyrosine kinase activity. Hence, both ErbB-2 and ErbB-3 are active only in the context of ErbB heterodimers, and ErbB-2. ErbB-3 heterodimers, which are driven by neuregulin ligands, are the most prevalent and potent complexes. These stringently controlled heterodimers are repeatedly employed throughout embryonic development and dictate the establishment of several cell lineages through mesenchyme-epithelial inductive processes and the interactions of neurons with muscle, glia, and Schwann cells. Likewise, the potent combination of signaling pathways engaged by the heterodimers drives an aggressive phenotype of tumors of secretory epithelia, including breast and lung cancers. This review highlights recent structural insights into the mechanism of ligand-induced heterodimer formation, and concentrates on signaling pathways employed by ErbB-2 and ErbB-3 in normal and in malignant cells.
Similar articles
- A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD, Przypadlo CM, Buck A, Herbener N, Riedel B, Schäfer L, Nakagawa H, Walch A, Reinheckel T, Werner M, Lassmann S. Fichter CD, et al. J Pathol. 2017 Dec;243(4):481-495. doi: 10.1002/path.4987. Epub 2017 Nov 5. J Pathol. 2017. PMID: 28940194 Free PMC article. - Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
Ram TG, Hosick HL, Ethier SP. Ram TG, et al. J Cell Physiol. 2000 Jun;183(3):301-13. doi: 10.1002/(SICI)1097-4652(200006)183:3<301::AID-JCP2>3.0.CO;2-W. J Cell Physiol. 2000. PMID: 10797304 - ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling.
Pinkas-Kramarski R, Alroy I, Yarden Y. Pinkas-Kramarski R, et al. J Mammary Gland Biol Neoplasia. 1997 Apr;2(2):97-107. doi: 10.1023/a:1026343528967. J Mammary Gland Biol Neoplasia. 1997. PMID: 10882296 Review. - ErbB receptors: directing key signaling networks throughout life.
Holbro T, Hynes NE. Holbro T, et al. Annu Rev Pharmacol Toxicol. 2004;44:195-217. doi: 10.1146/annurev.pharmtox.44.101802.121440. Annu Rev Pharmacol Toxicol. 2004. PMID: 14744244 Review. - Biology of HER2 and its importance in breast cancer.
Yarden Y. Yarden Y. Oncology. 2001;61 Suppl 2:1-13. doi: 10.1159/000055396. Oncology. 2001. PMID: 11694782 Review.
Cited by
- Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells.
Wang S, Huang J, Lyu H, Lee CK, Tan J, Wang J, Liu B. Wang S, et al. Cell Death Dis. 2013 Mar 21;4(3):e556. doi: 10.1038/cddis.2013.79. Cell Death Dis. 2013. PMID: 23519125 Free PMC article. - 17AAG-induced internalisation of HER2-specific Affibody molecules.
Göstring L, Lindegren S, Gedda L. Göstring L, et al. Oncol Lett. 2016 Oct;12(4):2574-2580. doi: 10.3892/ol.2016.4990. Epub 2016 Aug 10. Oncol Lett. 2016. PMID: 27698830 Free PMC article. - Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder Cancer.
Thomas J, Sonpavde G. Thomas J, et al. Cancers (Basel). 2022 Apr 1;14(7):1795. doi: 10.3390/cancers14071795. Cancers (Basel). 2022. PMID: 35406567 Free PMC article. Review. - Constitutive activation of neuregulin/ERBB3 signaling pathway in clear cell sarcoma of soft tissue.
Schaefer KL, Brachwitz K, Braun Y, Diallo R, Wai DH, Zahn S, Schneider DT, Kuhnen C, Vollmann A, Brockhoff G, Gabbert HE, Poremba C. Schaefer KL, et al. Neoplasia. 2006 Jul;8(7):613-22. doi: 10.1593/neo.06238. Neoplasia. 2006. PMID: 16867224 Free PMC article. - Darpp-32 and t-Darpp protein products of PPP1R1B: Old dogs with new tricks.
Avanes A, Lenz G, Momand J. Avanes A, et al. Biochem Pharmacol. 2019 Feb;160:71-79. doi: 10.1016/j.bcp.2018.12.008. Epub 2018 Dec 12. Biochem Pharmacol. 2019. PMID: 30552871 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous